SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:prod.swepub.kib.ki.se:146104530"
 

Search: id:"swepub:oai:prod.swepub.kib.ki.se:146104530" > DNA-launched RNA re...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in mice

Szurgot, I (author)
Karolinska Institutet
Hanke, L (author)
Karolinska Institutet
Sheward, DJ (author)
Karolinska Institutet
show more...
Vidakovics, LP (author)
Karolinska Institutet
Murrell, B (author)
Karolinska Institutet
McInerney, GM (author)
Karolinska Institutet
Liljestrom, P (author)
show less...
 (creator_code:org_t)
2021-02-04
2021
English.
In: Scientific reports. - : Springer Science and Business Media LLC. - 2045-2322. ; 11:1, s. 3125-
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The outbreak of the SARS-CoV-2 virus and its rapid spread into a global pandemic made the urgent development of scalable vaccines to prevent coronavirus disease (COVID-19) a global health and economic imperative. Here, we characterized and compared the immunogenicity of two alphavirus-based DNA-launched self-replicating (DREP) vaccine candidates encoding either SARS-CoV-2 spike glycoprotein (DREP-S) or a spike ectodomain trimer stabilized in prefusion conformation (DREP-Secto). We observed that the two DREP constructs were immunogenic in mice inducing both binding and neutralizing antibodies as well as T cell responses. Interestingly, the DREP coding for the unmodified spike turned out to be more potent vaccine candidate, eliciting high titers of SARS-CoV-2 specific IgG antibodies that were able to efficiently neutralize pseudotyped virus after a single immunization. In addition, both DREP constructs were able to efficiently prime responses that could be boosted with a heterologous spike protein immunization. These data provide important novel insights into SARS-CoV-2 vaccine design using a rapid response DNA vaccine platform. Moreover, they encourage the use of mixed vaccine modalities as a strategy to combat SARS-CoV-2.

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view